An open-label study of subdermal implants of estradiol-onlyversussubdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability

Abstract

Women treated with 17-beta estradiol-only silastic implants or 17-beta estradiol plus nomegestrol acetate silastic implants showed significant improvement of postmenopausal symptoms, including urogenital and sexual health symptoms and a significant increase in HDL cholesterol and no significant differences in other lipid profiles and tolerability.